Sirius Investors
145.98
0.46%Today
Market Cap
11.02B
Volume
488.79K
52W High
179.60
52W Low
131.76

No historical price data available

No price history data available for the selected time period.

Try selecting a different time range.

Company Overview

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company provides disease management services to 16,000 patients in risk-based integrated care arrangements and 7,000 patients in other integrated care arrangements; vascular access services; clinical research programs; physician services; and comprehensive kidney care services. As of December 31, 2021, it provided dialysis and administrative services in the United States through a network of 2,815 outpatient dialysis centers serving approximately 203,100 patients; and operated 339 outpatient dialysis centers located in 10 countries outside of the United States serving approximately 39,900 patients. Further, the company provides acute inpatient dialysis services in approximately 850 hospitals and related laboratory services in the United States. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.

Company Information

CEO
Javier J. Rodriguez
Sector
Healthcare
Industry
Medical - Care Facilities
Employees
76000

Contact Information

Address
2000 16th Street
Country
US

Investment Analysis & Insights

Key Investment Highlights

  • Market Position: Healthcare leader with 11.02B market capitalization
  • Trading Volume: 488.79K shares traded today
  • Price Range: 52-week range of $131.76 - $179.60
  • Exchange: Listed on New York Stock Exchange

Financial Metrics

P/E Ratio:14.50
EPS:$10.07
Beta:1.11
Avg Volume:807.77K

Market Analysis for DaVita Inc.

DaVita Inc. (DVA) operates in the Medical - Care Facilities industry within the Healthcare sector. With a current market capitalization of 11.02B, the company represents a significant player in its market. The stock is currently trading at $145.98 with a positivedaily change of 0.46%.

The company's 76000 employee base and presence on the New York Stock Exchangeexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of 14.50, beta of 1.11, and 52-week price range from $131.76 to $179.60when evaluating investment opportunities.

Why Invest in DaVita Inc.?

Strengths
  • • Established market presence in Healthcare
  • • Strong financial metrics and market position
  • • Listed on major exchange (New York Stock Exchange)
  • • Experienced leadership under Javier J. Rodriguez
Investment Considerations
  • • Monitor sector-specific market trends
  • • Track quarterly earnings performance
  • • Consider market volatility and beta
  • • Evaluate long-term growth potential